QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms
Clinical trial NCT07560449 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07560449
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.